206 related articles for article (PubMed ID: 31785928)
21. Endothelial calreticulin deletion impairs endothelial function in aged mice.
Biwer LA; Askew-Page HR; Hong K; Milstein J; Johnstone SR; Macal E; Good ME; Bagher P; Sonkusare SK; Isakson BE
Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1041-H1048. PubMed ID: 32196361
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.
Agarwal R; Blombery P; McBean M; Jones K; Fellowes A; Doig K; Forsyth C; Westerman DA
Ann Hematol; 2017 May; 96(5):725-732. PubMed ID: 28161773
[TBL] [Abstract][Full Text] [Related]
23. Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms.
Andrici J; Farzin M; Clarkson A; Sioson L; Sheen A; Watson N; Toon CW; Koleth M; Stevenson W; Gill AJ
Pathology; 2016 Jun; 48(4):319-24. PubMed ID: 27114372
[TBL] [Abstract][Full Text] [Related]
24. Diversities of Calreticulin Gene Mutations in Macedonian Patients With Essential Thrombocythemia.
Panovska-Stavridis I; Eftimov A; Ivanovski M; Stojanovic A; Georgievski B; Cevreska L; Dimovski AJ
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):477-81. PubMed ID: 27521277
[TBL] [Abstract][Full Text] [Related]
25. [New disease markers within the chronic myeloproliferative neoplasms].
Holmström MO; Ocias LF; Kallenbach K; Kjær L; Kristensen TK; Pallisgaard N; Petersen BL; Skov V; de Stricker K; Larsen TS; Hasselbalch HC
Ugeskr Laeger; 2015 May; 177(19):. PubMed ID: 25967091
[TBL] [Abstract][Full Text] [Related]
26. Calreticulin Affects Hematopoietic Stem/Progenitor Cell Fate by Impacting Erythroid and Megakaryocytic Differentiation.
Salati S; Prudente Z; Genovese E; Pennucci V; Rontauroli S; Bartalucci N; Mannarelli C; Ruberti S; Zini R; Rossi C; Bianchi E; Guglielmelli P; Tagliafico E; Vannucchi AM; Manfredini R
Stem Cells Dev; 2018 Feb; 27(4):225-236. PubMed ID: 29258411
[TBL] [Abstract][Full Text] [Related]
27. Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasms.
Angona A; Alvarez-Larrán A; Bellosillo B; Longarón R; Camacho L; Fernández-Rodríguez MC; Pairet S; Besses C
Leuk Res; 2016 Sep; 48():11-5. PubMed ID: 27427771
[TBL] [Abstract][Full Text] [Related]
28. Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer.
Holmström MO; Cordua S; Skov V; Kjær L; Pallisgaard N; Ellervik C; Hasselbalch HC; Andersen MH
Cancer Immunol Immunother; 2020 Feb; 69(2):315-324. PubMed ID: 31915854
[TBL] [Abstract][Full Text] [Related]
29. Development of a Targeted Next-Generation Sequencing Assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms.
Frawley T; O'Brien CP; Conneally E; Vandenberghe E; Percy M; Langabeer SE; Haslam K
Genet Test Mol Biomarkers; 2018 Feb; 22(2):98-103. PubMed ID: 29323541
[TBL] [Abstract][Full Text] [Related]
30. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
[TBL] [Abstract][Full Text] [Related]
31. Differential expression and molecular interactions of chromosome region maintenance 1 and calreticulin exportins in breast cancer cells.
Cruz-Ramos E; Sandoval-Hernández A; Tecalco-Cruz AC
J Steroid Biochem Mol Biol; 2019 Jan; 185():7-16. PubMed ID: 29981820
[TBL] [Abstract][Full Text] [Related]
32. Targeted delivery of calreticulin to ED-A fibronectin leads to tumor-growth retardation.
Ziffels B; Grötsch A; Al-Bayati L; Neri D
J Biotechnol; 2019 Jan; 290():53-58. PubMed ID: 30579890
[TBL] [Abstract][Full Text] [Related]
33. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.
Garg AD; Dudek AM; Ferreira GB; Verfaillie T; Vandenabeele P; Krysko DV; Mathieu C; Agostinis P
Autophagy; 2013 Sep; 9(9):1292-307. PubMed ID: 23800749
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of calreticulin exposure associated with immunogenic cell death.
Liu P; Zhao L; Kepp O; Kroemer G
Methods Enzymol; 2020; 632():1-13. PubMed ID: 32000891
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone-Mediated Upregulation of Calreticulin Inhibits Primary Human Glioblastoma Dispersal Ex Vivo.
Nair M; Romero J; Mahtabfar A; Meleis AM; Foty RA; Corbett SA
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29443896
[TBL] [Abstract][Full Text] [Related]
36. Calreticulin increases growth and progression of natural killer/T-cell lymphoma.
Zheng Y; Li C; Xin P; Peng Q; Zhang W; Liu S; Zhu X
Aging (Albany NY); 2020 Nov; 12(23):23822-23835. PubMed ID: 33221760
[TBL] [Abstract][Full Text] [Related]
37. Calreticulin is required for development of the cumulus oocyte complex and female fertility.
Tokuhiro K; Satouh Y; Nozawa K; Isotani A; Fujihara Y; Hirashima Y; Matsumura H; Takumi K; Miyano T; Okabe M; Benham AM; Ikawa M
Sci Rep; 2015 Sep; 5():14254. PubMed ID: 26388295
[TBL] [Abstract][Full Text] [Related]
38. Calreticulin (CALR) promotes ionophore-induced microneme secretion in Toxoplasma gondii.
Shan Z; Song X; Yang X; Xue Y; Wu Y; Wang X; Liu J; Liu Q
Parasitol Res; 2024 Feb; 123(2):139. PubMed ID: 38381180
[TBL] [Abstract][Full Text] [Related]
39. Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms.
Guo H; Chen X; Tian R; Chang J; Li J; Tan Y; Xu Z; Ren F; Zhao J; Pan J; Zhang N; Wang X; He J; Yang W; Wang H
PLoS One; 2015; 10(9):e0138250. PubMed ID: 26375990
[TBL] [Abstract][Full Text] [Related]
40. Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants.
Pecquet C; Chachoua I; Roy A; Balligand T; Vertenoeil G; Leroy E; Albu RI; Defour JP; Nivarthi H; Hug E; Xu E; Ould-Amer Y; Mouton C; Colau D; Vertommen D; Shwe MM; Marty C; Plo I; Vainchenker W; Kralovics R; Constantinescu SN
Blood; 2019 Jun; 133(25):2669-2681. PubMed ID: 30902807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
